Stock Events

Stock Events

BGM Group 

$8.00
18
-$0.15-1.84% 20:39 Today
+$0.85+10.62%21:00After hours

Statistics

Day High
9.54
Day Low
9.54
52W High
302.4
52W Low
6.45
Volume
655
Avg. Volume
8,054
Mkt Cap
106.83M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-52.59%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
37.92MRevenue
-19.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BGM. It's not an investment recommendation.
Apple
2
AAPL
Microsoft
2
MSFT
Realty Income
2
O
Amazon
2
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.74B
Zai Lab Limited operates in the biopharmaceutical sector in China, focusing on developing innovative medicines, directly competing with Qilian's pharmaceutical products.
HUTCHMED (China) Limited
HCM
Mkt Cap2.29B
Hutchison China MediTech Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in oncology and autoimmune diseases, similar to Qilian's focus areas.
Sinovac Biotech
SVA
Mkt Cap642.44M
Sinovac Biotech Ltd. specializes in the research, development, manufacturing, and commercialization of vaccines, competing with Qilian in the broader biopharmaceutical sector.
Can-Fite Biopharma
CANF
Mkt Cap4.91M
Can-Fite BioPharma Ltd. is a biotechnology company developing drugs for cancer, liver, and inflammatory diseases, areas that overlap with Qilian's product development.
Karyopharm Therapeutics
KPTI
Mkt Cap15.02M
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company that focuses on the discovery and development of novel drugs for the treatment of cancer and other major diseases, competing in the oncology segment with Qilian.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, including competition in the therapeutic areas targeted by Qilian.
Merck
MRK
Mkt Cap368.89B
Merck & Co., Inc. is a global healthcare company that offers health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products, competing across several of Qilian's business areas.

About

BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
Show More
CEO
Chen Xin
Employees
471
Country
China
ISIN
KYG7307E1310

Listings

XNAS
US
BGM
BOATS
BOATS
BGM.BOATS

0 Comments

Share your thoughts

FAQs

What is BGM Group stock price today?▼
The current price of BGM is $8.00 USD — it has decreased by -1.84% in the past 24 hours. Watch BGM Group stock price performance more closely on the chart.
What is BGM Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange BGM Group stocks are traded under the ticker BGM.
Is BGM Group stock price growing?▼
BGM stock has fallen by -4.76% compared to the previous week, the month change is a -14.35% fall, over the last year BGM Group has showed a -97.18% decrease.
What is BGM Group market cap?▼
Today BGM Group has the market capitalization of 106.83M
What is BGM Group revenue for the last year?▼
BGM Group revenue for the last year amounts to 37.92M USD.
What is BGM Group net income for the last year?▼
BGM net income for the last year is -19.94M USD.
How many employees does BGM Group have?▼
As of November 2, 2026, the company has 471 employees.
In which sector is BGM Group located?▼
BGM Group operates in the Health & Wellness sector.
When did BGM Group complete a stock split?▼
The last stock split for BGM Group was on October 1, 2026 with a ratio of 1:30.
Where is BGM Group headquartered?▼
BGM Group is headquartered in Chengdu, China.